• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童糖尿病研究。III:住院康复对I型和II型糖尿病患者代谢控制的影响——一年随访

The KID Study. III: Impact of inpatient rehabilitation on the metabolic control of type I and type II diabetics--a one-year follow-up.

作者信息

Haupt E, Herrmann R, Benecke-Timp A, Vogel H, Hilgenfeldt J, Haupt A, Walter C

机构信息

Saale-Klinik der BfA, Bad Kissingen, Germany.

出版信息

Exp Clin Endocrinol Diabetes. 1996;104(6):420-30. doi: 10.1055/s-0029-1211480.

DOI:10.1055/s-0029-1211480
PMID:9021342
Abstract

The Kissingen Diabetes Intervention Study (KID) evaluated 1050 diabetic patients of the German Federal Insurance Institution for Salaried Employees (BfA) admitted for inpatient rehabilitation. The data for the prospective longitudinal study (which was collected in a single center) relate to the structure of the patient cohort, socio-economic and psychological factors and the mode of medical management at the time of admission and discharge. Data regarding the same variables was checked by random testing six and twelve months after discharge and used in this part of the study. This cohort of patients is especially interesting for aspects of health policy because it comprises rather young diabetics engaged in highly qualified professional work. Therapy modifications entailing a more intensive insulin regimen were necessary in 20.7% of all type I diabetics. Most of these alterations were maintained over the following 12 months of management by the general practitioner. Improvement of HbA1 levels was related to the number of daily insulin administrations. The results obtained during inpatient treatment in patients on ICT are maintained even one year after their discharge. For type I diabetics, the first training measure especially results in a long-term improvement of the metabolic situation, whereas patients who have already received training several times previously benefit continuously less with increasing repetition of training. After twelve months the intensified insulin therapy of type I diabetics had no further effect on the BMI or the already previously normal serum lipids. In 55.5% of all type II diabetics, the therapy had to be modified. Inpatient rehabilitation resulted in raising the low number of type II diabetics treated just with diet by 5.3%. This proportion was again slightly reduced 12 months later. During inpatient residence the number of overweight type II diabetics treated with drugs was reduced both in the group on oral hypoglycemics and in the group on pre-mixed insulin, according to the weight loss achieved. On the other hand, it was often necessary to intensify the usual insulin regimen twice daily in the group of younger patients with normal body weight. These modifications were maintained twelve months after the stay in hospital for most of these patients. Virtually all type II diabetics on oral hypoglycemics are overweight as a reflection of too early prescriptions of oral hypoglycemics which often neglects the chance of a dietary management only. In this group, therapy modifications were directed towards treatment with diet only and with oral hypoglycemics having an extra-pancreatic action. On metformin, the HbA1 was reduced by 0.3% and the BMI by 0.9 kg/m2 even 12 months later. In the 90% of type II diabetics previously treated with sulphonylureas (almost exclusively glibenclamide), re-modification of therapy from metformin back to the old regimen (16:9%) was especially high. This is probably due to the uncertainty with and general restrictions in the prescription of metformin in the relevant period 1991 to 1995. The results 12 months after inpatient treatment show the small improvement of HbA1 and serum lipids as already seen in other larger interventional studies. The BMI does not change significantly within the relatively short follow-up period. The best long-term results are achieved by a combined therapy with sulphonylurea compounds and metformin. The KID study demonstrates major deficits in intensifying the insulin regimen of type I diabetics and in the individual adaptation to therapy of type II diabetes in Germany, even when younger patients of higher professional status are considered. Interventional inpatient rehabilitation improves their metabolic situation with lasting effect and can compensate deficits in outpatient management by the general practitioner. However, future concepts have to be improved at all levels of diabetic management, with a view to achieving an optimum interaction.

摘要

基辛根糖尿病干预研究(KID)对德国联邦受薪雇员保险机构(BfA)收治的1050例糖尿病患者进行了住院康复评估。这项前瞻性纵向研究(在单一中心收集数据)的数据涉及患者队列结构、社会经济和心理因素以及入院和出院时的医疗管理模式。出院后6个月和12个月通过随机检测对相同变量的数据进行了检查,并用于本研究的这一部分。这组患者在卫生政策方面特别具有研究价值,因为其中包括从事高素质专业工作的相对年轻的糖尿病患者。20.7%的所有I型糖尿病患者需要进行治疗调整,采用更强化的胰岛素治疗方案。在随后由全科医生管理的12个月中,这些调整大多得以维持。糖化血红蛋白(HbA1)水平的改善与每日胰岛素注射次数有关。接受胰岛素持续皮下输注(ICT)治疗的患者在住院治疗期间取得的结果,即使在出院一年后仍能维持。对于I型糖尿病患者,首次训练措施尤其能带来代谢状况的长期改善,而之前已经接受过多次训练的患者,随着训练次数的增加,获益持续减少。12个月后,I型糖尿病患者强化胰岛素治疗对体重指数(BMI)或之前已正常的血脂没有进一步影响。55.5%的所有II型糖尿病患者需要调整治疗方案。住院康复使仅接受饮食治疗的少数II型糖尿病患者比例提高了5.3%。12个月后,这一比例再次略有下降。在住院期间,根据体重减轻情况,口服降糖药组和预混胰岛素组中接受药物治疗的超重II型糖尿病患者数量均有所减少。另一方面,在体重正常的年轻患者组中,通常需要将每日两次的常规胰岛素治疗方案强化。这些患者出院12个月后,大多数患者的这些调整得以维持。几乎所有服用口服降糖药的II型糖尿病患者都超重,这反映出口服降糖药处方过早,往往忽略了仅通过饮食管理的可能性。在这组患者中,治疗调整主要针对仅采用饮食治疗以及使用具有胰腺外作用的口服降糖药。即使在12个月后,使用二甲双胍治疗,糖化血红蛋白降低了0.3%,体重指数降低了0.9kg/m²。在之前接受磺脲类药物(几乎全是格列本脲)治疗的90%的II型糖尿病患者中,从二甲双胍治疗重新调整回旧治疗方案(16:9%)的比例特别高。这可能是由于在1991年至1995年相关期间,二甲双胍处方存在不确定性和普遍限制。住院治疗12个月后的结果显示,糖化血红蛋白和血脂有小幅改善,这在其他更大规模的干预研究中也已观察到。在相对较短的随访期内,体重指数没有显著变化。磺脲类化合物与二甲双胍联合治疗可取得最佳长期效果。基辛根糖尿病干预研究表明,即使考虑到专业地位较高的年轻患者,德国在强化I型糖尿病患者的胰岛素治疗方案以及II型糖尿病的个体化治疗方面仍存在重大缺陷。住院干预康复可改善他们的代谢状况,并产生持久效果,还可弥补全科医生门诊管理的不足。然而,未来的理念必须在糖尿病管理的各个层面加以改进,以期实现最佳的相互作用。

相似文献

1
The KID Study. III: Impact of inpatient rehabilitation on the metabolic control of type I and type II diabetics--a one-year follow-up.儿童糖尿病研究。III:住院康复对I型和II型糖尿病患者代谢控制的影响——一年随访
Exp Clin Endocrinol Diabetes. 1996;104(6):420-30. doi: 10.1055/s-0029-1211480.
2
The KID study IV: effects of inpatient rehabilitation on the frequency of glucose self-monitoring, quality of further primary care, on time being unable to work and on everyday psychic strain of type I and type II diabetics--a one-year follow-up. Kissingen Diabetes Intervention Study.基德研究IV:住院康复对I型和II型糖尿病患者血糖自我监测频率、后续初级护理质量、无法工作时间以及日常精神压力的影响——一年随访。基辛根糖尿病干预研究
Exp Clin Endocrinol Diabetes. 1997;105(1):21-31. doi: 10.1055/s-0029-1211723.
3
The KID Study. II: Socioeconomic baseline characteristics, psycho-social strain, standard of current medical care and education of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation. Kissingen Diabetes Intervention Study.基德研究。二:德国联邦受薪雇员保险机构(BfA)糖尿病患者在住院康复期间的社会经济基线特征、心理社会压力、当前医疗护理标准及教育情况。基辛根糖尿病干预研究。
Exp Clin Endocrinol Diabetes. 1996;104(5):378-86. doi: 10.1055/s-0029-1211471.
4
The KID Study. I: Structural baseline characteristics of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation. Kissingen Diabetes Intervention Study.基德研究。一:住院康复中受雇员工联邦保险机构(BfA)糖尿病患者的结构基线特征。基辛根糖尿病干预研究。
Exp Clin Endocrinol Diabetes. 1996;104(5):370-7. doi: 10.1055/s-0029-1211470.
5
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.瑞格列奈:对其在2型糖尿病治疗中应用的药物经济学综述
Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005.
6
Long-term impact of a structured group-based inpatient-education program for intensive insulin therapy in patients with diabetes mellitus.糖尿病患者强化胰岛素治疗的结构化团体住院教育项目的长期影响。
Wien Klin Wochenschr. 2010 Jun;122(11-12):341-5. doi: 10.1007/s00508-010-1398-x. Epub 2010 Jun 25.
7
Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics.中年非胰岛素依赖型糖尿病患者的血脂和脂蛋白
Atherosclerosis. 1985 Sep;56(3):271-81. doi: 10.1016/0021-9150(85)90003-6.
8
[Inpatient medical rehabilitation in diabetes mellitus in light of evidence based practice guidelines: an evaluation on the basis of BfA routine data].基于循证实践指南的糖尿病住院医疗康复:基于德国法定健康保险机构常规数据的评估
Rehabilitation (Stuttg). 2003 Apr;42(2):94-108. doi: 10.1055/s-2003-38812.
9
United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.英国前瞻性糖尿病研究24:一项为期6年的随机对照试验,比较磺脲类药物、胰岛素和二甲双胍疗法对新诊断的、饮食疗法无法控制的2型糖尿病患者的疗效。英国前瞻性糖尿病研究小组。
Ann Intern Med. 1998 Feb 1;128(3):165-75. doi: 10.7326/0003-4819-128-3-199802010-00001.
10
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.二甲双胍强化血糖控制对超重2型糖尿病患者并发症的影响(英国前瞻性糖尿病研究34)。英国前瞻性糖尿病研究(UKPDS)小组。
Lancet. 1998 Sep 12;352(9131):854-65.

引用本文的文献

1
[Medical rehabilitation. Basic function of the German pension insurance].[医学康复。德国养老保险的基本功能]
Internist (Berl). 2010 Oct;51(10):1219-20, 1922-4, 1926-30. doi: 10.1007/s00108-010-2625-2.